Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study-Reference-Cited by-同舟云学术

Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study

Published:2017-07-07 Issue:7 Volume:12 Page:e0165415
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Landi Doriana,Albanese Maria,Buttari Fabio,Monteleone Fabrizia,Boffa Laura,Rossi Silvia,Motta Caterina,Puma Elisa,Centonze Diego

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatment in multiple sclerosis;N Scolding;Pract Neurol,2015

2. Interferon-ß-1b: a review of its use in multiple sclerosis;GL Plosker;CNS Drugs,2011

3. Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis;H Moses Jr;Curr Med Res Opin,2008

4. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study;SC Steinberg;Clin Drug Investig,2010

5. Improving compliance with interferon-beta therapy in patients with multiple sclerosis;E Portaccio;CNS Drugs,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Apigenin-3 Acetate versus Apigenin and Methyl-Prednisolone in Inhibiting Proliferation and Gene Expression of Th1 Cells in Multiple Sclerosis;CELL J;2023

2. A review of possible therapies for multiple sclerosis;Molecular and Cellular Biochemistry;2021-04-22

3. Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis;Current Gene Therapy;2020-04-25

4. Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study;Journal of Neurology;2020-03-05

5. Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In Vitro;Inflammation;2019-02-26